1 / 8

Proctor & Gamble Co. (PG) Analysis: Key Metrics and Recent Developments

Proctor & Gamble Co. (PG) is a leading consumer product manufacturer with products like Tide, Charmin, CoverGirl, and Iams. With a market cap of $176.7 billion, PG is traded on NYSE. The company has shown a P/E ratio of 16.3, an annual dividend of $2.10, and a recent share price of $64.21, indicating fair value at $72. Recent developments include a joint venture with Teva Pharmaceuticals and a positive outlook following the sale of the Pringles business. Analysts recommend a strong buy with significant growth potential.

luella
Télécharger la présentation

Proctor & Gamble Co. (PG) Analysis: Key Metrics and Recent Developments

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Proctor & Gamble Co.(PG):Consumer Staples by Amanda Fitzpatrick 11/10/11

  2. Overview • One of the world’s largest consumer product manufacturers, which are sold through three global business units, which include products such as: • Tide Laundry Detergent, Charmin Toilet Paper, cover Girl Cosmetics, and Iams Pet Food • Market Cap.: $176.7 B • 52 week range: $57.76-$67.72 • Annual Dividend Rate: $2.10 • Traded on NYSE

  3. Key Statistics P/E: 16.3 Industry: 16 Debt/Equity: 51.88 Industry: 5.25 EPS Growth 5 Yr: 9.95 Industry: 1.05 Net Profit Margin: 13.92 (TTM) Industry: 11.93 (TTM) ROE: 18.32 (TTM) Industry: 2.12 (TTM) Recent Price : $64.21 (fair value= $72.00) Purchase Price : $61.84 Shares : 65 YTD Return: -3.8% Holding Return: 0.1%

  4. Recent News • Announced a new joint venture with Teva Pharmaceutical (TEVA.O) to sell over-the-counter medicines (early October 2011) • Raised its full-year profit outlook to reflect gains from the $1.5 billion sale of its Pringles snacks business • Signed a “Master Collaboration Agreement” for Joint Research and Development with Hebrew University Through this, scientists and researchers from P&G will be partnering with the university to study areas such as biology and chemistry to develop “cutting-edge innovations” to possible impact their products

  5. Stock Evaluation

  6. - 05/16/2008 Chart- 5 years

  7. Chart- 1 year

  8. Analysts Recommendations Strong Buy: 9 Buy: 9 Hold: 5 Underperform: 1 Sell: 0

More Related